Clinical Trials A continuación, se enumeran los ensayos clínicos actuales.253 estudios en Cancer (solo estudios abiertos). Filtra esta lista de estudios por sede, estado, etc. TRPC6 To Predict And Prevent Chemotherapy Related Cardiomyopathy And Heart Failure (Prospective Study) Jacksonville, Fla. The purpose of this study is to characterize TRPC6 risk variants for doxorubicin-related cardiotoxicity in prospectively collected samples from breast cancer patients. Breast cancer patients are more than three times at risk for developing congestive heart failure (CHF), compared with patients who did not have cancer. The increased risk of HF is observed as early as one year from diagnosis of cancer and overall, 7% of patients develop CHF (median follow-up 8.5 years) Blood And Urine Identification Of Methylated DNA Markers In Invasive Bladder Carcinoma Rochester, Minn. The purpose of this study is to, in tissue, discover and validate DNA methylation markers (MDMs) for detection of invasive urothelial carcinoma of the bladder. In blood, to assess the accuracy of candidate MDMs from above for detection of invasive urothelial carcinoma of the bladder. In urine, to explore the accuracy of candidate MDMs from above for detection of invasive urothelial carcinoma of the bladder. Diagnostic accuracy on urine can be compared with that on plasma using paired samples. Global Cardio Oncology Registry Rochester, Minn. The purpose of this study is to provide a large database and platform for prospective sub-studies and eventually develop additional collaborations with a platform for clinical studies and trials following the initial pilot phase. Numeración de páginas Estudios clínicos AnteriorPágina anterior Ir a página 2424 Ir a página 2525 Ir a página 2626 Profesionales médicos Cancer clinical-trials